US 7235573
Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
granted A61KA61K31/426A61K31/655
Quick answer
US patent 7235573 (Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors) held by The Regents of the University of California expires Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jun 26 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/426, A61K31/655, A61P, A61P43/00